Leerink Partners analyst, Danielle Antalffy, increased the price target of Outperform rated Johnson & Johnson (NYSE: JNJ) to $140 from ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE